Clinical Trials Directory

Trials / Completed

CompletedNCT05195346

Undetectable = Untransmissible in Thailand (888/64)

A Cross-sectional Survey of HIV Healthcare Providers and People Living With HIV in Thailand, and Their Awareness, Knowledge, and Implementation of Undetectable = Untransmissible

Status
Completed
Phase
Study type
Observational
Enrollment
770 (actual)
Sponsor
Institute of HIV Research and Innovation Foundation, Thailand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a cross-sectional study to assess awareness, knowledge, and implementation of the concept of U=U among Thai PLHIV and Thai HIV healthcare providers, as well as associated factors. Data will be collected on an online survey platform called Alchemer. Questions on the survey will evaluate awareness, knowledge, and implementation of U=U among participants, as well as collect sociodemographic information of participants.

Detailed description

Recruitment Recruitment will start with the distribution of a brief description of the survey, along with the link to the questionnaire itself. This will be distributed systematically through the use of the snowball sampling method on popular social networking platforms (such as Line, Instagram, WhatsApp, Facebook and Twitter), where 'seed' distributors, who may be categorised into different groups (such as age, gender identity and treatment facility for PLHIV or healthcare facility and type of healthcare provider for HIV healthcare providers), will share out links to a number of friends. Participants will be enrolled into the study once they click on the link leading them to the survey and complete the questionnaire. Informed consent process Consent will be obtained by action. A brief description of the survey will be distributed, along with the online link to the survey, which will be on SurveyGizmo. All data will be collected anonymously. A digitalised consent form will be presented to participants before they start the survey, which will outline the potential risks and benefits. All participants will be equal to or over the age of 18; therefore, parental consent is not needed. Questionnaires The questionnaire should take no more than 15 minutes to complete. The survey will be completed on Alchemer (formerly SurveyGizmo), a flexible, cross platform online survey software, or other popular online survey platforms with similar features, with the participant giving consent through action. Questions on the survey will evaluate awareness, knowledge, and implementation of U=U among participants, as well as collect sociodemographic information of participants. All the information collected will be kept confidential and anonymous, and participants cannot be identified in any way. There will be two different questionnaires, one for PLHIV and one for HIV healthcare providers; each survey will be slightly altered to for the appropriate participant category. After the questionnaire is completed, participants can choose to be redirected to educational webpages with more information on U=U. Data analysis Data used for analysis will only include data that is submitted through the online portal. It will be analysed using descriptive statistics including percentage, mean and standard deviations, as well as inferential statistics such as Chi Square test or t-test depending on the characteristics of data

Conditions

Timeline

Start date
2021-12-01
Primary completion
2024-03-01
Completion
2024-03-01
First posted
2022-01-18
Last updated
2024-03-12

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT05195346. Inclusion in this directory is not an endorsement.